Back to blog
Bioenergetics & Carb MetabolismMarch 17, 2026

Q-Bank Breakdown: Glycolysis regulation — Why Every Answer Choice Matters

Q-Bank Breakdown: Glycolysis Regulation — Why Every Answer Choice Matters

Tag: Biochemistry > Bioenergetics & Carb Metabolism

Glycolysis questions are rarely about memorizing the pathway—they’re about recognizing regulatory logic under physiologic stress (fasting vs feeding, high ATP vs low ATP, hypoxia, alcohol use, sepsis, etc.). This breakdown uses a classic clinical-style vignette to show how each answer choice maps to a real regulatory node.

Clinical Vignette (USMLE-Style)

A 24-year-old man is brought to the ED after being found unconscious. He is tachypneic and diaphoretic. Labs show: glucose 54 mg/dL, lactate elevated, pH 7.22. After IV dextrose, his mental status improves. In hepatocytes shortly after dextrose administration, which change most directly increases glycolytic flux?

Answer Choices

A. Increased fructose-2,6-bisphosphate concentration
B. Increased glucagon signaling leading to phosphorylation of PFK-2
C. Increased ATP binding to phosphofructokinase-1 (PFK-1)
D. Increased citrate concentration
E. Increased activity of fructose-1,6-bisphosphatase (FBPase-1)

Correct Answer: A. Increased fructose-2,6-bisphosphate concentration

Why it’s correct (mechanism)

In the fed state (after dextrose), insulin rises, which promotes glycolysis in the liver. The key regulatory “switch” is fructose-2,6-bisphosphate (F2,6BP):

  • F2,6BP strongly activates PFK-1 → drives glycolysis forward
  • F2,6BP inhibits FBPase-1 → suppresses gluconeogenesis
  • It is made by PFK-2 (part of the bifunctional enzyme PFK-2/FBPase-2)

The high-yield integration

  • PFK-1 is the rate-limiting enzyme of glycolysis (committed step: fructose-6-P → fructose-1,6-bisphosphate).
  • F2,6BP is the most important allosteric regulator of PFK-1 in the liver in response to insulin/glucagon signaling.
  • In the fed state: insulin → dephosphorylation of the bifunctional enzyme → PFK-2 active → ↑ F2,6BP → ↑ glycolysis.

Why Each Distractor Is Wrong (and What It’s Testing)

B. Increased glucagon signaling leading to phosphorylation of PFK-2

This describes the fasting state, not the post-dextrose state.

In liver:

  • Glucagon → ↑ cAMP → PKA activation → phosphorylation of PFK-2/FBPase-2
  • Phosphorylation makes FBPase-2 active and PFK-2 inactive
  • Result: ↓ F2,6BP → ↓ PFK-1 activity → ↓ glycolysis, ↑ gluconeogenesis

USMLE high-yield pearl:

  • The phosphorylation effect is tissue-specific (liver vs heart isoenzymes differ), but for Step exams, the classic rule is: glucagon inhibits hepatic glycolysis and promotes gluconeogenesis.

C. Increased ATP binding to phosphofructokinase-1 (PFK-1)

ATP is not just a substrate—it’s also a negative allosteric regulator of PFK-1.

  • High ATP signals high energy status
  • ATP binds an allosteric inhibitory site on PFK-1
  • Result: ↓ glycolysis

Contrast that with low-energy signals:

  • AMP (and ADP) activate PFK-1 (signal low energy)
  • F2,6BP powerfully activates PFK-1 (especially in liver)

D. Increased citrate concentration

Citrate is a “we have plenty of building blocks and energy” signal and inhibits PFK-1.

  • Citrate rises when the TCA cycle is backed up (energy abundant)
  • It promotes slowing glycolysis and shifting toward storage/biosynthesis
  • Result: ↓ PFK-1 activity → ↓ glycolysis

High-yield link: Citrate also supports fatty acid synthesis (exported from mitochondria to cytosol).

E. Increased activity of fructose-1,6-bisphosphatase (FBPase-1)

FBPase-1 is a key gluconeogenic enzyme (the “reverse” bypass of PFK-1).

  • FBPase-1 converts fructose-1,6-bisphosphate → fructose-6-phosphate
  • Increased FBPase-1 activity = ↑ gluconeogenesis
  • It is inhibited by F2,6BP and AMP
  • Result: counteracts glycolysis, especially in liver

USMLE framing:
If the question asks what increases glycolysis, anything that activates gluconeogenesis is usually a trap—look for reciprocal regulation.

The Regulation Map You Need (PFK-1 vs FBPase-1)

PFK-1 (Glycolysis “GO”)

Activated by:

  • AMP
  • Fructose-2,6-bisphosphate

Inhibited by:

  • ATP
  • Citrate
  • Low pH (important in exercising muscle—limits lactic acidosis)

FBPase-1 (Gluconeogenesis “GO”)

Activated by:

  • (Often conceptualized as) high energy state

Inhibited by:

  • AMP
  • Fructose-2,6-bisphosphate

Step-Style Takeaways (Ultra High-Yield)

  • Rate-limiting step of glycolysis: PFK-1
  • Most important hepatic regulator responding to hormones: F2,6BP
  • Insulin (fed) → dephosphorylation → PFK-2 active → ↑ F2,6BP → ↑ glycolysis
  • Glucagon (fasting) → phosphorylation → FBPase-2 active → ↓ F2,6BP → ↓ glycolysis + ↑ gluconeogenesis
  • ATP/citrate inhibit PFK-1; AMP activates PFK-1
  • F2,6BP activates PFK-1 and inhibits FBPase-1 (reciprocal control prevents futile cycling)

Rapid “How to Pick the Answer” Test-Day Strategy

When you see “increase glycolysis in liver”, ask:

  1. Is this fed (insulin) or fasting (glucagon) physiology?
  2. For fed physiology, choose anything that increases F2,6BP or activates PFK-1.
  3. Eliminate anything that:
    • raises ATP or citrate (inhibitors), or
    • activates gluconeogenesis enzymes like FBPase-1.

SEO Guidelines

Meta Description:
Master glycolysis regulation for USMLE with a Q-bank style breakdown: how insulin, glucagon, fructose-2,6-bisphosphate, ATP, citrate, and gluconeogenesis enzymes control PFK-1—and why each distractor is wrong.

Focus Keywords:

  • glycolysis regulation
  • PFK-1 regulation
  • fructose-2,6-bisphosphate
  • PFK-2 FBPase-2 insulin glucagon
  • biochemistry USMLE glycolysis
  • gluconeogenesis vs glycolysis regulation